NCT00305227View on ClinicalTrials.gov

Intravaginal LACTIN-V for Prevention of Recurrent Urinary Tract Infection

PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

April 30, 2012

Study Completion Date

April 30, 2012

Conditions
Urinary Tract Infection
Interventions
DRUG

Lactin-V

DRUG

Placebo

Trial Locations (1)

98195

Hall Health Primary Care Center, University of Washington, Seattle

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

collaborator

Osel, Inc.

INDUSTRY

lead

University of Washington

OTHER

NCT00305227 - Intravaginal LACTIN-V for Prevention of Recurrent Urinary Tract Infection | Biotech Hunter | Biotech Hunter